Hims & Hers Health Soars 10.38% on Volatile Intraday Move—What’s Fueling This Surge?

Summary
• HIMS jumps over 10% in a single trading session to hit $20.73 at 17:48 EST
• Intraday range of $18.64 to $21.00 shows sharp consolidation
• Leveraged ETFs like HIMZ and HIYY follow suit with gains of 21.44% and 9.32%
• Options chain sees explosive activity with high-volume contracts near $18.50 and $18 strikes

Hims & Hers Health (HIMS) delivered a striking performance in March’s final trading session, rallying nearly 10.4% after opening flat at previous close. The stock’s sharp intraday reversal coincided with a surge in leveraged ETFs and heavy options trading. As the market digests technical divergence and short-term volatility, traders are now turning to key price levels and derivative activity for clues on where this momentum might go next.

Options Volatility and Short-Term Bulls Ignite HIMS' Rebound
The explosive 10.38% gain in HIMS today was driven by a sharp reversal in options market sentiment. Multiple high-volume call options were traded, especially around the $18.50 and $18 strike prices with an expiration date of April 10, 2026. These contracts displayed high leverage ratios and implied volatility of 101.40% to 105.56%, suggesting a strong short-term bullish bet. The sharp rebound came as the stock found support near its 30-day moving average of $19.46 and bounced off its intraday low of $18.64, sparking a rapid technical recovery.

Options and ETFs to Watch in the Volatile HIMS Landscape
• 200-day average: 40.348 (far above)
• 30-day average: 19.460 (near)
• RSI: 34.08 (oversold)
• MACD: -0.164 (bearish), Signal: 0.131, Histogram: -0.295
• Bollinger Bands: Upper 27.98, Middle 21.34, Lower 14.71
• Support zone (30D): 15.66–15.88
• Resistance zone (200D): 47.58–48.62

HIMS is currently trading in a sharp short-term bounce from oversold RSI territory. The stock has found support near its 30-day moving average and is showing early signs of reversal. For traders, the key levels to watch are the 200-day average at $40.35 and the 30-day support at $15.66–$15.88. The leveraged ETF HIMZ is a compelling tool for those seeking amplified exposure, especially with its 21.44% intraday gain.

• HIMS20260410C18.5 (Call Option):
• Code: HIMS20260410C18.5
• Type: Call
• Strike: $18.50
• Expiration: 2026-04-10
• IV: 97.25% (High Volatility)
• Leverage Ratio: 7.76% (Moderate)
• Delta: 0.771 (High Sensitivity)
• Theta: -0.100 (Moderate Time Decay)
• Gamma: 0.0868 (High Sensitivity to Price Changes)
• Turnover: 14,731 (High Liquidity)

This call option is a strong short-term play given its high gamma and high IV. With a 111.11% price change ratio, this contract is attracting significant volume, showing strong bullish sentiment. A 5% upside from current price would yield a strike price of $21.77, offering a solid profit margin of $3.27 per contract.

• HIMS20260410P18 (Put Option):
• Code: HIMS20260410P18
• Type: Put
• Strike: $18.00
• Expiration: 2026-04-10
• IV: 101.40% (Very High Volatility)
• Leverage Ratio: 6.62% (Moderate)
• Delta: 0.809 (High Sensitivity)
• Theta: -0.0988 (Moderate Time Decay)
• Gamma: 0.0748 (High Sensitivity to Price Changes)
• Turnover: 2,978 (Moderate Liquidity)

This put option is positioned to capitalize on a sharp reversal. A 5% upside in HIMS would see a put payoff of zero, but the option’s high delta and gamma make it an attractive hedge against volatility. Traders bearish on HIMS can also use this as a high-liquidity entry point.

With the technicals pointing toward potential consolidation and a possible breakout, aggressive bulls should consider HIMS20260410C18.5 into a bounce above $21.00.

Backtest Hims & Hers Health Stock Performance
The backtest of Hims & Hers Health (HIMS) following a 10% intraday increase from 2022 to the present shows favorable short-to-medium-term performance. The 3-Day win rate is 50.39%, the 10-Day win rate is 56.05%, and the 30-Day win rate is 58.01%, indicating a higher probability of positive returns in the immediate aftermath of the surge. The maximum return during the backtest period was 16.60%, which occurred on day 59 after the event, suggesting that there is potential for continued upward momentum.

Time for HIMS to Reclaim Key Resistance or Face a Bearish Reversal
HIMS is at a critical juncture. The recent rally has brought the stock closer to its 30-day moving average and has pulled it out of oversold territory, suggesting a short-term technical rebound. However, the long-term bearish trend remains intact, with the 200-day average at $40.35 far out of reach. With high-volume options activity and leveraged ETFs showing strong momentum, it's clear the market is pricing in a potential breakout. Investors should closely monitor the $21.00 intraday high and watch for a sustained break above it. Medtronic (MDT), the sector leader, remains relatively flat with a 0.31% move, but HIMS' volatility is outpacing the sector. If this momentum holds, HIMS20260410C18.5 could offer a high-gamma way to capitalize on the move. Watch for a confirmed breakout above $21.00 or a breakdown below $18.64 to determine the next directional move.